Deerfield
About Deerfield

Launched in 1994, Deerfield Management Company is an investment firm dedicated to advancing healthcare through information, investment, and philanthropy—all toward the end goal of cures for disease, improved quality of life, and reduced cost of care.

Read More
---
Investment

Supporting companies across the healthcare ecosystem with flexible funding models…

Read More
---
Information

Delivering market research to the Deerfield team, its portfolio companies and other partners.

Read More ---
Philanthropy

A New York City-based not-for-profit devoted to advancing innovative health care initiatives.

Read More
---
Portfolio Companies

Deerfield generally maintains a combined portfolio of more than 150 private and public investments across the life science, medical device, diagnostic, digital health and health service industries at all stages of evolution from start-up to mature company.

Read More View Portfolio Companies
---
Research Collaborations

Deerfield partners with leading academic research centers, providing critical funding and expertise to further sustain and accelerate the commercialization of discoveries toward meaningful societal impact by advancing cures for disease.

Read More View Research Collaborations
---
Strategic Partners

As a strategic partner, Deerfield offers capital, scientific expertise, business operating support, and unique access to innovation.

Read More
---
Deerfield Foundation

The Deerfield Foundation is a New York City-based not-for-profit organization whose mission is to improve health, accelerate innovation and promote human equity.

Read More Meet the Foundation Team
---
Cure Campus

Cure is a 12-story innovation campus in New York City that intends to bring together innovators from academia, government, industry, and the not-for-profit sectors to advance human health and accelerate the fight against disease.

Read More Join the Cure Email List
Cure Programming

Cure has a series of expert lectures intended to advance thought in healthcare, management, innovation, policy, and other relevant subjects. This fosters growth and education for those at Cure and its guests.

Events at the Cure

Deerfield Announces up to a $50 million Investment in Alphatec Spine

Deerfield Management Company announced today that it has provided Alphatec Spine (NASDAQ: ATEC) with up to $50 million in financing. The financing supplies Alphatec with capital to satisfy certain obligations arising out of the Orthotec, LLC litigation and growth capital for future commercial activities.

Alphatec Spine has the option to draw up to $50 million in one or more increments prior to January 30th, 2015.  With each disbursement, Deerfield will receive a transaction fee of 2.5% of the amount drawn.  Amounts drawn accrue interest at 8.75% per annum, payable quarterly in cash, and must be repaid in five years.  Alphatec additionally issued Deerfield 6.25 million warrants and will issue up to an additional 10 million warrants on a pro rata basis as the facility is drawn down. The warrants will expire on the sixth anniversary of the agreement. 

“Deerfield has been a long-term investor in Alphatec and is supportive of the Company’s growth plan. Our goal with this facility is to help Alphatec move beyond this legal matter and to provide additional capital for managing its growth,” stated Steve Hochberg, a partner at Deerfield Management.

“Deerfield has demonstrated its commitment to Alphatec’s future potential and we value the continued support that it is providing through this additional financial investment,” said Les Cross,Chairman and CEO of Alphatec Spine. “With this legal matter with OrthoTec behind us, we are able to focus our full attention on strengthening and growing our business based on the strong foundation and momentum we have established,” added Mr. Cross.

About Alphatec Spine

Alphatec Spine, Inc., a wholly owned subsidiary of Alphatec Holdings, Inc., is a medical device company that designs, develops, manufactures and markets physician-inspired products and solutions for the treatment of spinal disorders associated with trauma, congenital deformities, disease and degeneration. The Company’s mission is to combine innovative surgical solutions with world-class customer service to improve outcomes and patient quality of life. The Company and its affiliates market products in the U.S. and in over 50 countries internationally via a direct sales force and independent distributors.   Additional information can be found at www.alphatecspine.com.

About Deerfield Management Company

Deerfield is an investment management firm, committed to advancing healthcare through investment, information and philanthropy. For more information about Deerfield, please visit www.deerfield.com

Contacts

Deerfield Management Company
Karen Heidelberger, 212-692-7140
[email protected]